CNS Disorders  >>  memantine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

35 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT00234637: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Completed
4
204
Europe
Rivastigmine, memantine
Novartis
Alzheimer's Disease
06/05
06/05
NCT00368862: Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Completed
4
80
Europe
Ebixa (memantine hydrochloride), Cipralex (escitalopram)
Finnish Institute for Health and Welfare, Finnish Foundation for Alcohol Studies
Alcoholism, Depression
 
06/06
NCT00305903: Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease

Completed
4
150
US
Rivastigmine, memantine
Novartis
Alzheimer's Disease
 
08/07
NCT00757978: Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

Completed
4
22
RoW
memantine, Ebixa, placebo, Starch
Hospital de Clinicas de Porto Alegre
Schizophrenia
01/08
03/08
NCT00505167: Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Completed
4
64
Europe
Memantine, Ebixa (Memantine), Donepezil, Aricept (Donepezil)
Hospital Miguel Servet, Clinica Quiron de Zaragoza, Universidad de Zaragoza, Hospital de Barbastro, Hospital Royo Villanova
Dementia, Alzheimer Type
07/08
12/08
NCT01921972: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

Completed
4
232
Europe
Galantamine CR, Memantine, Placebo
Charite University, Berlin, Germany, German Federal Ministry of Education and Research
Alzheimer's Disease
11/08
05/09
NCT00855686: Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

Completed
4
199
Europe
Memantine, Ebixa®, Placebo
H. Lundbeck A/S
Parkinson's Disease Dementia, Dementia With Lewy Bodies
12/08
01/09
NCT00862940: A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease

Completed
4
277
Europe
Memantine, Ebixa®, Placebo
H. Lundbeck A/S
Alzheimer's Disease
02/09
04/09
MemAP, NCT00649220 / 2007-004489-41: Memantine and Antipsychotics Use

Terminated
4
19
Europe
Memantine
Merz Pharmaceuticals GmbH
Alzheimer's Disease
05/09
06/09
NCT00183729: Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults

Completed
4
35
US
Memantine, Namenda, Placebo
Eric Lenze, National Institute of Mental Health (NIMH)
Depression
06/09
06/09
MAGD, NCT00371059 / 2005-005087-93: Memantine for Agitation in Dementia

Completed
4
153
Europe
Memantine, Placebo
East Kent Hospitals University NHS Foundation Trust, University of Oxford, Institute of Psychiatry, London, University of London, University College, London, Indiana University School of Medicine
DEMENTIA
06/09
09/09
NCT00768261: Corticolimbic Degeneration and Treatment of Dementia

Completed
4
39
NA
Memantine (Namenda®), Namenda, Donepezil (Aricept®), Aricept
Washington University School of Medicine, Northwestern University
Dementia
10/09
10/09
NCT00586573: Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

Completed
4
34
US
memantine hydrochloride, Namenda
Massachusetts General Hospital
ADHD
10/09
10/09
NCT00401167: Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Completed
4
31
Canada
memantine
Sunnybrook Health Sciences Centre, Lundbeck Canada Inc.
Alzheimer's Disease
01/10
01/10
FOGG-I, NCT01108029 / 2008-008210-38: Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Completed
4
28
Europe
memantine, EBIXA, placebo
University Hospital, Lille
Parkinson's Disease, Gait Disorders, Neurologic
09/10
10/10
NCT00800709: Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Completed
4
26
RoW
Memantine, Memantine hydrochloride
Shanghai Mental Health Center, H. Lundbeck A/S
Alzheimer's Disease
10/10
10/10
NCT00305578: Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression

Completed
4
29
US
Memantine, Memantine or Namenda, Placebo
Indiana University School of Medicine
Bipolar Depression
12/10
12/11
DOMINO-AD, NCT00866060 / 2007-001172-36: Donepezil and Memantine in Moderate to Severe Alzheimer's Disease

Unknown status
4
800
Europe
Memantine, Ebixa, Donepezil, Aricept, Placebo donepezil, Placebo memantine
King's College London
Moderate to Severe Alzheimer's Disease
02/12
06/13
ROMEO-AD, NCT01849042: Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease

Unknown status
4
188
RoW
Ebixa, donepezil
Konkuk University Medical Center
Alzheimer's Disease, Dementia
08/14
08/15
2005-004498-31: Behaviour and cognition in Alzheimer s disease patients treated with the NMDA receptor antagonist memantine collelation with the apoptotic mechanisms.

Ongoing
4
40
Europe
EBIXA 10MG 56 CPR RIV, EBIXA 10MG 56 CPR RIV
FONDAZIONE SANTA LUCIA
Treatment of patients with Alzheimer s Disease
 
 
2007-004897-26: Memantine for the Long Term Management of Neuropsychiatric Symptoms in Alzheimer\'s disease - MAIN-AD

Ongoing
4
300
Europe
Memantine, Risperidone, Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary), Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary)
King\'s College London, North Essex Partnership NHS Foundation Trust
Alzheimer\'s disease
 
 
2010-024543-33: Can memantine prevent memory impairment induced by MDMA in humans

Completed
4
16
Europe
Memantine, MDMA, MDMA, Ebixa, Ebixa
Maastricht University
none
 
 
NCT02553928: Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Completed
4
62
RoW
Memantine (once daily), Lu 00-800, Ebixa ®, Ebix ®, Memantine (twice daily)
H. Lundbeck A/S
Alzheimer Dementia (AD)
07/16
07/16
NCT01656187: Attenuation of Corticosteroid Induced Hippocampal Changes

Completed
4
46
US
Memantine 10 mg capsule, Namenda, Memantine-matched Placebo capsule, Sugar pill
University of Texas Southwestern Medical Center, National Institute on Drug Abuse (NIDA)
Organic Memory Impairment
01/17
01/17
2016-004097-17: The main purpose of this clinical trial is to introduce a method for dertermination drugs in biological samples ( plasma, cerebrospinal fluid or urine ) and their subsequent use. Hlavním cílem je zavést metodu pro stanovení léčiva v biologických vzorcích ( plasma, mozkomíšní mok, popř. moč ) a její následné využití.

Completed
4
32
Europe
MEMANTINE TEVA, Capsule, MEMANTINE TEVA
Fakultni nemocnice Hradec Kralove, Neurologická klinika Fakultní nemocnice Hradec Králové
Alzheimer's disease Alzheimerova choroba, Alzheimer's disease Alzheimerova choroba, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT03168997: Memantine Treatment in Alzheimer's Disease Patients

Unknown status
4
222
NA
Memantine Hydrochloride, Memantine
Wei Cuibai
Alzheimer Disease
09/18
12/18
NCT01902004: Brain Aging and Treatment Response in Geriatric Depression

Completed
4
115
US
Escitalopram, Lexapro, Memantine, Namenda, Placebo, inactive substance
University of California, Los Angeles, National Institute of Mental Health (NIMH)
Mild Cognitive Impairment (MCI), Depression
01/19
01/19
NCT03860597: Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia

Completed
4
42
US
Memantine, Placebos
University of California, San Diego
Schizophrenia, Schizo Affective Disorder, Schizoaffective Disorder, Healthy
03/21
03/21
NCT03779672: Memantine for Epileptic Encephalopathy

Completed
4
30
Canada
Memantine Hydrochloride 10 mg, PrSANDOZ MEMANTINE FCT10 mg Drug Identification Number (DIN) 02375532
Kenneth Myers, MD
Epileptic Encephalopathy, Childhood-Onset
11/21
02/22
MONANTI, NCT04117178 / 2017-002707-10: Monitoring Anti-Dementia Drugs by Serum Levels

Completed
4
132
Europe
Donepezil, Memantine, Measurement of serum level of anti-dementia drug
Zealand University Hospital, Filadelfia Epilepsy Hospital
Dementia, Dementia With Lewy Bodies, Dementia in Parkinsons Disease, Dementia Alzheimers, Alzheimer Disease
02/23
02/23
NCT03954613: Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease

Recruiting
4
198
RoW
Ebicomb, Donepezil-Memantine
Neutec Ar-Ge San ve Tic A.Åž
Alzheimer Disease, Cognitive Change
03/23
03/24
ChiCTR2000035209: Effects of Memantine on glutamate metabolism in patients with moderate to severe depression: a randomized controlled trial.

Not yet recruiting
4
60
 
combination therapy ;Anti-5-ht antidepressant should be administered alone
The Second Affiliated Hospital of Xinxiang Medical University; The Second Affiliated Hospital of Xinxiang Medica University, Henan Provincial Clinical Research Center for Mental and Psychological Diseases opens the project
depression
 
 
NCT03703856: Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

Recruiting
4
32
US
Memantine, Placebo
University of California, San Diego
Alzheimer Disease
06/24
06/24
NCT05430867: Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

Not yet recruiting
4
150
NA
Memantine Oral Tablet, Memantine, GV-971 capsule, GV-971
First Affiliated Hospital Xi'an Jiaotong University
Treatment, Efficacy, Safety, Alzheimer Disease
07/24
12/24
ChiCTR2300071719: Evaluation of the efficacy and safety of Memantine hydrochloride oral membranes in the treatment of moderate-to-severe and severe senile dementia patients in real-world settings: a multicenter registry study

Not yet recruiting
4
2000
 
N/A
The Second Hospital, Cheeloo College of Medicine, Shandong University; The Second Hospital, Cheeloo College of Medicine, Shandong University, enterprise
Senile dementia
 
 

Download Options